Literature DB >> 22786459

A framework for "driving under the influence of drugs" policy for the opioid using driver.

Brian G Wilhelmi1, Steven P Cohen.   

Abstract

BACKGROUND: Driving under the influence of drugs (DUID) is a term used to designate the action of driving an automobile after the consumption of drugs or medications other than alcohol that interfere with the capacity to operate a vehicle safely. Unlike recreational drugs, prescription medications pose a unique challenge to those attempting to harness their benefits yet protect the driving public. As studies demonstrate a steady increase in opioid use and abuse in the United States, these same constituencies must regulate a significant percentage of drivers who are under the influence of opioids.
OBJECTIVE: This article examines current DUID policy and attempts to present unified suggestions for improvement based on best scientific evidence of opioid-induced psychomotor impairment. STUDY
DESIGN: Literature Review
METHODS: A literature search was conducted regarding the epidemiology of opioid use and abuse, psychomotor effects of opioids, DUID, and state policy concerning DUID. A total of 23 epidemiological studies, 3 studies on acute psychomotor effects, 32 on chronic psychomotor effects, and selected pertinent law and policy were reviewed.
RESULTS: Current state law concerning DUID is variable and often relies on prosecutorial discretion to provide protection of the driving public and prosecution of the truly impaired. LIMITATIONS: The design of various studies included in this review imposes limitations on the epidemiological data extracted. Relationships between opioids and automobile accidents are commonly reviewed in retrospect. The data on opioid-induced psychomotor impairment and its effects on driving an automobile require further direct study to examine current inferences.
CONCLUSIONS: A sizable percentage of the driving public has detectable levels of opioids within their bodies. The best available evidence demonstrates psychomotor impairment following acute administration of opioids or an increase in opioid dosage, but impairment diminishes with chronic, stable opioid usage. Policy makers must account for this evidence when balancing the benefit of pain relief against the need for public roadway protection when drafting DUID legislation.

Entities:  

Mesh:

Year:  2012        PMID: 22786459

Source DB:  PubMed          Journal:  Pain Physician        ISSN: 1533-3159            Impact factor:   4.965


  13 in total

1.  Effect of chronic opioid therapy on actual driving performance in non-cancer pain patients.

Authors:  Markus B Schumacher; Stefan Jongen; Anja Knoche; Frank Petzke; Eric F Vuurman; Mark Vollrath; Johannes G Ramaekers
Journal:  Psychopharmacology (Berl)       Date:  2017-02-12       Impact factor: 4.530

2.  Prevalence of Self-Reported Prescription Drug Use in a National Sample of U.S. Drivers.

Authors:  Tara Kelley-Baker; Geetha Waehrer; Robin A Pollini
Journal:  J Stud Alcohol Drugs       Date:  2017-01       Impact factor: 2.582

3.  Driving reaction time before and after anterior cervical fusion for disc herniation: a preliminary study.

Authors:  Ricarda Lechner; Martin Thaler; Martin Krismer; Christian Haid; Jochen Obernauer; Alois Obwegeser
Journal:  Eur Spine J       Date:  2013-03-10       Impact factor: 3.134

4.  Effect of opioids on sleep and breathing in chronic pain patients.

Authors:  M Jeffery Mador; Jennifer Henderson
Journal:  J Clin Sleep Med       Date:  2014-08-15       Impact factor: 4.062

5.  Marijuana use trajectories among drug-using youth presenting to an urban emergency department: Violence and social influences.

Authors:  Maureen A Walton; Quyen Epstein-Ngo; Patrick M Carter; Marc A Zimmerman; Frederic C Blow; Anne Buu; Jason Goldstick; Rebecca M Cunningham
Journal:  Drug Alcohol Depend       Date:  2017-02-03       Impact factor: 4.492

Review 6.  Basic concepts in opioid prescribing and current concepts of opioid-mediated effects on driving.

Authors:  Adam M Kaye; Alan D Kaye; Elise C Lofton
Journal:  Ochsner J       Date:  2013

7.  Potential for Harm Associated with Discharge Opioids After Hospital Stay: A Systematic Review.

Authors:  Gerardo A Arwi; Stephan A Schug
Journal:  Drugs       Date:  2020-04       Impact factor: 9.546

8.  Receipt of Warnings Regarding Potentially Impairing Prescription Medications and Associated Risk Perceptions in a National Sample of U.S. Drivers.

Authors:  Robin A Pollini; Geetha Waehrer; Tara Kelley-Baker
Journal:  J Stud Alcohol Drugs       Date:  2017-11       Impact factor: 2.582

9.  Prevalence and Correlates of Driving Under the Influence of Cannabis in the U.S.

Authors:  Christopher P Salas-Wright; Manuel Cano; Audrey Hang Hai; Sehun Oh; Michael G Vaughn
Journal:  Am J Prev Med       Date:  2021-03-13       Impact factor: 6.604

Review 10.  Naloxone's role in the national opioid crisis-past struggles, current efforts, and future opportunities.

Authors:  Alex S Bennett; Luther Elliott
Journal:  Transl Res       Date:  2021-03-05       Impact factor: 10.171

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.